Nektar Therapeutics | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
237,026.00
262,824.00
308,944.00
389,102.00
296,132.00
1,335
Total Accounts Receivable
2,229.00
3,607.00
19,947.00
15,678.00
5,014.00
43
Inventories
13,452.00
12,952.00
11,346.00
11,109.00
10,726.00
38
Other Current Assets
5,175.00
8,817.00
9,814.00
10,363.00
14,948.00
21
Total Current Assets
257,882.00
288,200.00
350,051.00
426,252.00
326,820.00
1,438
Net Property, Plant & Equipment
66,974.00
70,368.00
71,336.00
65,601.00
47,463.00
49
Total Investments and Advances
25,000.00
-
-
-
57,088.00
583
Intangible Assets
76,501.00
76,501.00
76,501.00
76,501.00
76,501.00
77
Other Assets
8,170.00
6,552.00
754.00
517.00
994.00
4
Total Assets
434,527.00
441,621.00
498,642.00
568,871.00
508,866.00
2,150
ST Debt & Current Portion LT Debt
7,000.00
4,512.00
4,756.00
2,908.00
-
Accounts Payable
9,115.00
2,703.00
2,363.00
2,816.00
4,782.00
Other Current Liabilities
82,106.00
56,832.00
54,127.00
66,498.00
51,381.00
Total Current Liabilities
98,221.00
64,047.00
61,246.00
72,222.00
56,163.00
Long-Term Debt
254,569.00
228,722.00
338,182.00
331,925.00
320,993.00
Other Liabilities
171,640.00
112,520.00
92,785.00
76,599.00
43,882.00
Total Liabilities
524,430.00
405,289.00
492,213.00
480,746.00
421,038.00
Common Equity (Total)
89,903.00
36,332.00
6,429.00
88,125.00
87,828.00
Total Shareholders' Equity
89,903.00
36,332.00
6,429.00
88,125.00
87,828.00
Total Equity
89,903.00
36,332.00
6,429.00
88,125.00
87,828.00
Liabilities & Shareholders' Equity
434,527.00
441,621.00
498,642.00
568,871.00
508,866.00
About Nektar Therapeutics
View Profile
